Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome

Molecular and Cellular Proteomics

Volumn 10, Issue 10, 2011, Pages

  Britschgi, Markus ^a,i   Rufibach, Kaspar ^b   Bauer Huang, Sarah L ^a   Clark, Christopher M ^c   Kaye, Jeffrey A ^d   Li, Ge ^e   Peskind, Elaine R ^e,f   Quinn, Joseph F ^d   Galasko, Douglas R ^g   Wyss Coray, Tony ^a,h  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f Education   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h VA PALO ALTO HEALTH CARE SYSTEM   (United States)

ⁱ F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; PROTEOME; TAU PROTEIN; AMYLOID PRECURSOR PROTEIN; BIOLOGICAL MARKER; PEPTIDE FRAGMENT; PLASMA PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MATHEMATICAL MODEL; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; AGED; BLOOD; CELL COMMUNICATION; CEREBROSPINAL FLUID; FEMALE; MALE; METABOLISM; NEUROIMAGING; PATHOLOGY; PROTEIN CEREBROSPINAL FLUID LEVEL; SIGNAL TRANSDUCTION; THEORETICAL MODEL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; BIOLOGICAL MARKERS; BLOOD PROTEINS; CELL COMMUNICATION; CEREBROSPINAL FLUID PROTEINS; FEMALE; HUMANS; MALE; MODELS, THEORETICAL; NEUROIMAGING; PEPTIDE FRAGMENTS; PROTEOME; SIGNAL TRANSDUCTION; TAU PROTEINS;

EID: 80054042479     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.008862     Document Type: Article

References (42)

1. Steinman, L. (2008) Nuanced roles of cytokines in three major human brain disorders. J. Clin. Invest. 118, 3557-3563
2. Perry, V. H., Cunningham, C., and Holmes, C. (2007) Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 7, 161-167 (Pubitemid 46174862)
3. Alzheimer's Association National Office (2011) 2011 Alzheimer's Disease Facts and Figures. Alzheimer's Association National Office, IL
4. Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., Dekosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., Gauthier, S., Hampel, H., Jicha, G. A., Meguro, K., O'Brien, J., Pasquier, F., Robert, P., Rossor, M., Salloway, S., Sarazin, M., de Souza, L. C., Stern, Y., Visser, P. J., and Scheltens, P. (2010) Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol. 9, 1118-1127
5. Dubois, B., Feldman, H. H., Jacova, C., Dekosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., Meguro, K., O'brien, J., Pasquier, F., Robert, P., Rossor, M., Salloway, S., Stern, Y., Visser, P. J., and Scheltens, P. (2007) Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 6, 734-746 (Pubitemid 47058377)
6. Perrin, R. J., Fagan, A. M., and Holtzman, D. M. (2009) Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature 461, 916-922
7. De Meyer, G., Shapiro, F., Vanderstichele, H., Vanmechelen, E., Engelborghs, S., De Deyn, P. P., Coart, E., Hansson, O., Minthon, L., Zetterberg, H., Blennow, K., Shaw, L., and Trojanowski, J. Q. (2010) Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch. Neurol. 67, 949-956
8. Shaw, L. M., Vanderstichele, H., Knapik-Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., Dean, R., Siemers, E., Potter, W., Lee, V. M., and Trojanowski, J. Q. (2009) Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann. Neurol. 65, 403-413
9. Visser, P. J., Verhey, F., Knol, D. L., Scheltens, P., Wahlund, L. O., Freund-Levi, Y., Tsolaki, M., Minthon, L., Wallin, A. K., Hampel, H., Bürger, K., Pirttila, T., Soininen, H., Rikkert, M. O., Verbeek, M. M., Spiru, L., and Blennow, K. (2009) Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. Lancet Neurol. 8, 619-627
10. Fagan, A. M., Roe, C. M., Xiong, C., Mintun, M. A., Morris, J. C., and Holtzman, D. M. (2007) Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Arch Neurol. 64, 343-349 (Pubitemid 46425688)
11. Li, G., Sokal, I., Quinn, J. F., Leverenz, J. B., Brodey, M., Schellenberg, G. D., Kaye, J. A., Raskind, M. A., Zhang, J., Peskind, E. R., and Montine, T. J. (2007) CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study. Neurology 69, 631-639 (Pubitemid 47256004)
12. Okonkwo, O. C., Alosco, M. L., Griffith, H. R., Mielke, M. M., Shaw, L. M., Trojanowski, J. Q., and Tremont, G. (2010) Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease. Arch. Neurol. 67, 688-696
13. Fagan, A. M., Head, D., Shah, A. R., Marcus, D., Mintun, M., Morris, J. C., and Holtzman, D. M. (2009) Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly. Ann. Neurol. 65, 176-183
14. Britschgi, M., and Wyss-Coray, T. (2007) Systemic and acquired immune responses in Alzheimer's disease. Int. Rev. Neurobiol. 82, 205-233
15. Hu, W. T., Chen-Plotkin, A., Arnold, S. E., Grossman, M., Clark, C. M., Shaw, L. M., Pickering, E., Kuhn, M., Chen, Y., McCluskey, L., Elman, L., Karlawish, J., Hurtig, H. I., Siderowf, A., Lee, V. M., Soares, H., and Trojanowski, J. Q. (2010) Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment. Acta Neuropathol. 119, 669-678
16. O'Bryant, S. E., Xiao, G., Barber, R., Reisch, J., Doody, R., Fairchild, T., Adams, P., Waring, S., and Diaz-Arrastia, R. (2010) A serum protein-based algorithm for the detection of Alzheimer disease. Arch. Neurol. 67, 1077-1081
17. Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., Kaye, J. A., Leszek, J., Miller, B. L., Minthon, L., Quinn, J. F., Rabinovici, G. D., Robinson, W. H., Sabbagh, M. N., So, Y. T., Sparks, D. L., Tabaton, M., Tinklenberg, J., Yesavage, J. A., Tibshirani, R., and Wyss-Coray, T. (2007) Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med. 13, 1359-1362 (Pubitemid 350073592)
18. Soares, H. D., Chen, Y., Sabbagh, M., Roher, A., Rohrer, A, Schrijvers, E., and Breteler, M. (2009) Identifying early markers of Alzheimer's disease using quantitative multiplex proteomic immunoassay panels. Ann. N.Y. Acad. Sci. 1180, 56-67
19. Zhang, J., Sokal, I., Peskind, E. R., Quinn, J. F., Jankovic, J., Kenney, C., Chung, K. A., Millard, S. P., Nutt, J. G., and Montine, T. J. (2008) CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. Am. J. Clin. Pathol. 129, 526-529 (Pubitemid 352029270)
20. Booij, B. B., Lindahl, T., Wetterberg, P., Skaane, N. V., Sæbo, S., Feten, G., Rye, P. D., Kristiansen, L. I., Hagen, N., Jensen, M., Bårdsen, K., Winblad, B., Sharma, P., and Lönneborg, A. (2011) A gene expression pattern in blood for the early detection of Alzheimer's disease. J. Alzheimers Dis. 23, 109-119
21. Rye, P. D., Booij, B. B., Grave, G., Lindahl, T., Kristiansen, L., Andersen, H. M., Horndalsveen, P. O., Nygaard, H. A., Naik, M., Hoprekstad, D., Wetterberg, P., Nilsson, C., Aarsland, D., Sharma, P., and Lönneborg, A. (2011) A novel blood test for the early detection of Alzheimer's disease. J. Alzheimers Dis. 23, 121-129
22. Lucin, K. M., and Wyss-Coray, T. (2009) Immune activation in brain aging and neurodegeneration: too much or too little? Neuron 64, 110-122
23. Hixson, J. E., and Vernier, D. T. (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31, 545-548 (Pubitemid 20107994)
24. Li, G., Peskind, E. R., Millard, S. P., Chi, P., Sokal, I., Yu, C. E., Bekris, L. M., Raskind, M. A., Galasko, D. R., and Montine, T. J. (2009) Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects. PLoS One 4, e5424
25. R Development Core Team (2009) R: A language and environment for statistical computing., R Foundation for Statistical Computing, Vienna, Austria
26. van den Berg, R. A., Hoefsloot, H. C., Westerhuis, J. A., Smilde, A. K., and van der Werf, M. J. (2006) Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 7, 142
27. Zou, H., and Hastie, T. (2005) Regularization and variable selection via the elastic net. J. Roy. Statistical Soc. B 67, 301-320 (Pubitemid 40465877)
28. Friedman, J., Hastie, T., and Tibshirani, R. (2010) Regularization paths for generalized linear models via coordinate descent. J. Stat. Software 33, 1-22
29. Hanley, J. A., and McNeil, B. J. (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143, 29-36 (Pubitemid 12142173)
30. Pepe, M. (2003) The statistical evaluation of medical tests for classification and prediction, Oxford University Press
31. Villeda, S. A., Luo, J., Mosher, K. I., Zou, B., Britschgi, M., Bieri, G., Stan, T. M., Fainberg, N., Ding, Z., Eggel, A., Lucin, K. M., Czirr, E., Park, J.-S., Couillard-Després, S., Aigner, L., Li, G., Peskind, E. R., Kaye, J. A., Quinn, J. F., Galasko, D. R., Xie, X. S., Rando, T. A., and Wyss-Coray, T. (2011) The aging systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477, 90-94
32. Blennow, K., and Hampel, H. (2003) CSF markers for incipient Alzheimer's disease. Lancet Neurol. 2, 605-613 (Pubitemid 37162569)
33. Veerkamp, J. H., and Zimmerman, A. W. (2001) Fatty acid-binding proteins of nervous tissue. J. Mol. Neurosci. 16, 133-142; discussion 151-157
34. Pelsers, M. M., Hanhoff, T., Van der Voort, D., Arts, B., Peters, M., Ponds, R., Honig, A., Rudzinski, W., Spener, F., de Kruijk, J. R., Twijnstra, A., Hermens, W. T., Menheere, P. P., and Glatz, J. F. (2004) Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility. Clin. Chem. 50, 1568-1575 (Pubitemid 39121225)
35. Wunderlich, M. T., Hanhoff, T., Goertler, M., Spener, F., Glatz, J. F., Wallesch, C. W., and Pelsers, M. M. (2005) Release of brain-type and heart-type fatty acid-binding proteins in serum after acute ischaemic stroke. J. Neurol. 252, 718-724 (Pubitemid 40864047)
36. Zimmermann-Ivol, C. G., Burkhard, P. R., Le Floch-Rohr, J., Allard, L., Hochstrasser, D. F., and Sanchez, J. C. (2004) Fatty acid binding protein as a serum marker for the early diagnosis of stroke: a pilot study. Mol. Cell. Proteomics 3, 66-72 (Pubitemid 38697105)
37. Chiasserini, D., Parnetti, L., Andreasson, U., Zetterberg, H., Giannandrea, D., Calabresi, P., and Blennow, K. (2010) CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease. J. Alzheimers Dis. 22, 1281-1288
38. Hu, W. T., Chen-Plotkin, A., Arnold, S. E., Grossman, M., Clark, C. M., Shaw, L. M., McCluskey, L., Elman, L., Karlawish, J., Hurtig, H. I., Siderowf, A., Lee, V. M., Soares, H., and Trojanowski, J. Q. (2010) Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease. Acta Neuropathol. 120, 385-399
39. Boissonneault, V., Filali, M., Lessard, M., Relton, J., Wong, G., and Rivest, S. (2009) Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease. Brain 132, 1078-1092
40. Tsai, K. J., Tsai, Y. C., and Shen, C. K. (2007) G-CSF rescues the memory impairment of animal models of Alzheimer's disease. J. Exp. Med. 204, 1273-1280
41. Park, J., Lee, D. S., Christakis, N. A., and Barabási, A. L. (2009) The impact of cellular networks on disease comorbidity. Mol. Syst. Biol. 5, 262
42. Inouye, M., Kettunen, J., Soininen, P., Silander, K., Ripatti, S., Kumpula, L. S., Hämäläinen, E., Jousilahti, P., Kangas, A. J., Männistö, S., Savolainen, M. J., Jula, A., Leiviskä, J., Palotie, A., Salomaa, V., Perola, M., Ala-Korpela, M., and Peltonen, L. (2010) Metabonomic, transcriptomic, and genomic variation of a population cohort. Mol. Syst. Biol. 6, 441